Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-052787

President and CEO acquired 5,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Mack David Henry · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-08-19 Exercise or conversion : show line 1 in the form +5,500 $0.53 $2,915 17,970 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-08-19 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −5,500 441,574 D
Loading xslF345X03/doc4.xml…